Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
From Fragmented Symptoms to Structured Care: Advancing Menopause Management in Primary Practice
October 19, 2026 Nashville, Tennessee
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Erica L. Mayer, MD, MPH
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California
Turning Flares Into Function: Flag Uncontrolled Disease
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
The 2-Point Signal: Apply ≥2-Point Rule
When to Begin FcRn: Initiation Criteria, Key Evidence
Minimal By Design: Define MSE Endpoints
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Escalate With Intention: Stepwise, Target-Anchored Moves
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Target Locked in gMG: Why T2T Matters
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Shared Goals, Shared Gains: Align With Patient Preferences
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Clinical Considerations for the Diagnosis of Endometriosis
James A. Simon, MD, CCD, NCMP, IF, FACOG
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Lee P. Shulman, MD, FACMG, FACOG
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.